Abstract:
Method and apparatus performing dynamic contrast-enhanced - magnetic resonance imaging on tissue to obtain a plurality of datasets of images. Principal component analysis is performed on each dataset to obtain a covariance matrix and its corresponding eigenvalues and eigenvectors and produce a common base of eigenvectors. The dominant eigenvectors that are not associated with instrumental and random noise, commonly the 2nd eigen-state and the 3rd eigenvectors, or the 1st and 2nd eigen vectors, are correlated with the physiological relevant parameters of the 3TP method to obtain a hybrid method. The fusion of the eigenvectors with the 3TP parameters is dictating a rotation of the two relevant eigenvectors to obtain new rotated eigenvectors that serve to calculate new projection coefficient maps of the rotated eigenvectors for the imaged tissue indicative of physiological relevant parameters reflecting wash-out and wash-in patterns that detect abnormal tissue and distinguishes between cancerous and benign tumors. Computer-readable medium containing program instructions for carrying out the above.
Abstract:
SO-modified transgenic plants overexpressing or lacking SO activity, having modified tolerance or susceptibility to toxicity of sulfite-producing substances, methods for their production and the use thereof for bioremediation of pollutants, as sentinel plants, for enhancing post-harvest quality of plants, plant tissues and plant products and for therapeutic applications.
Abstract:
An agent selected from: (a) a pathogenic self-antigen associated with a T-cell-mediated specificautoimmune disease of an organ; (b) a peptide which sequence is comprised within the sequenceof (a); (c) a peptide obtained by modification of (b), by replacement of one or more amino acidresidues by different amino acid residues, said modified peptide still being capable of recognizingthe T-cell receptor recognized by the parent peptide but with less affinity; (d) a nucleotide sequenceencoding (a), (b), or (c) ; and (e) T cells activated by a pathogenic self-antigen of (a), a peptide of (b), or a modified peptide of (c), can be used for treatment of a non- autoimmunedisease, disorder or injury in said organ. For example, uveitogenic antigens or peptides thereof canbe used for treatment of a non-autoimmune disease, disorder or injury in the eye.
Abstract:
X-ray fluorescence is used for in vivo determining elements in prostate cancer. One preferred application is in determining level of Zn in prostate as means for diagnosing prostate cancer or staging the disease.